Martin Bryden and Dr. Nial Wheate join me from Canngea. We had a discussion about their business and what they are currently working on in the cannabis industry. We spoke on topics like the current state of the medical, nutraceutical, and recreational industries. Dr Nial Wheate broke down clinical trials and the bioavailability of cannabis. 

To let you know Canngea is an Australian company that operates as a B2B Contract Manufacturing Organisation. They focus on Eu-GMP standards (Good Management Practices) and SOP’s (Standard Operating Procedures). Canngea can deliver consistent high-quality products at competitive rates. 

They were established in Australia in September 2017. Canngea offers services to other companies in the medicinal cannabis industry to supply white label and private label solutions to produce products for wholesale in the domestic and international markets.

Today, Cannatrek is a leading Australian medicinal cannabis company specialising in cultivation, manufacturing, and digital healthcare distribution across Australia. They have a full suite of medicinal cannabis licenses which provide them with complete control of the entire product lifecycle, from growth and processing through to distribution and sales. Featuring a digital healthcare platform that connects doctors, patients, and pharmacists with their products, Cannatrek streamlines the entire medicinal cannabis process for all.

After 9 years of intensive design, development and commercial testing, VCT are proud to offer this leading development to the cannabis growing industry.

Every climate cell in a Cannabis Series system is automatically monitored. Managed to maintain pre-set temperature, humidity, CO², watering and LED lighting levels to achieve optimum plant growth for the crop varieties planted. Any variation from presets or system function error is automatically identified, logged and reported by SMS text message or email.